Maximizing Oncology Efficacy: 5-Fluorouracil Market Evolution and Forecast to 2031
The global oncology landscape continues to prioritize essential chemotherapeutic agents as the bedrock of multi-drug regimens. Among these, 5-Fluorouracil (5-FU) remains a critical antimetabolite used extensively in the treatment of solid tumors, including colorectal, breast, and gastrointestinal cancers. According to recent market analysis, the global 5-Fluorouracil market is expected to...
0 Comments 0 Shares 495 Views 0 Reviews